Table 2:
Characteristics of autoantibody positive participants by type 1 diabetes stage at baseline
| Single antibody positive | Stage 1 | Stage 2 | |
|---|---|---|---|
|
| |||
| N | 4,314 | 3,066 | 2,045 |
|
| |||
| Baseline age (yrs), mean (SD) | 14.2 (± 12.1) | 12.3 (± 10.3) | 13.5 (± 10.3) |
|
| |||
| Sex, N (%) | |||
| Male | 2,184 (50.6) | 1,682 (54.9) | 1,111 (54.3) |
| Female | 2,128 (49.3) | 1,383 (45.1) | 934 (45.7) |
| Missing | 2 (0.1) | 1 (0) | 0 (0) |
|
| |||
| Race, N (%) | |||
| White | 3,734 (86.6) | 2,686 (87.6) | 1,801 (88.1) |
| African American | 109 (2.5) | 84 (2.7) | 48 (2.3) |
| Other | 162 (3.8) | 101 (3.3) | 72 (3.4) |
| Missing | 309 (7.1) | 195 (6.4) | 124 (6.2) |
|
| |||
| Ethnicity, N (%) | |||
| Non-Hispanic | 3,708 (86) | 2,666 (87) | 1,773 (86.7) |
| Hispanic | 416 (9.6) | 253 (8.3) | 172 (8.4) |
| Missing | 190 (4.4) | 147 (4.7) | 100 (4.9) |
|
| |||
| GRS2, mean (SD) | 13.4 (± 2.1) | 13.8 (± 1.9) | 13.9 (± 1.8) |
|
| |||
| Follow-up (yrs), mean (SD) | 0.97 (± 1.68) | 1.6 (± 2.2) | 2.4 (± 2.6) |